Soleo Health operates 20 locations throughout the U.S. with national nursing coverage and pharmacy licensure in 50 states and is accredited by The Joint Commission
Optum Frontier Therapies Centers of Excellence (COEs) consist of dedicated teams focused on cell and gene therapy, rare disease drugs and digital therapeutics
Blueprint creates medicines that selectively target genetic drivers, with the goal of staying one step ahead across stages of disease
AnovoRx’s focus is intentionally centered on the unique needs of patients with chronic diseases who rely on specialty and orphan drugs as well as manufacturers
Biophama companies are increasingly interested in establishing relationships with experienced specialty pharmacies to dispense rare disease drugs to patients
Alnylam® Pharmaceuticals selected PantherRx Rare and Orsini Specialty Pharmacy as limited distribution partners for OXLUMO™ (lumasiran). OXLUMO is the first and only treatment approved for primary hyperoxaluria type 1 (PH1) to lower urinary oxalate levels in pediatric and adult patients. PH1 is an ultra-rare genetic disease characterized by the overproduction of oxalate, a waste product that […]
Biophama companies are increasingly interested in establishing relationships with experienced specialty pharmacies to dispense rare disease drugs to patients
RareMed Solutions is the nation’s only (pure) rare and devastating disorder patient service provider (PSP)